(Q34842204)

4 August 2017

1 reference

title

All in the head: obstacles for immune rejection of brain tumours (English)

1 reference

4 August 2017

Paul R Walker

1

1 reference

4 August 2017

Thomas Calzascia

series ordinal

2

1 reference

4 August 2017

Pierre-Yves Dietrich

series ordinal

3

1 reference

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

107

1 reference

4 August 2017

1

1 reference

4 August 2017

28-38

1 reference

Gliomagenesis: genetic alterations and mouse models

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunobiology of gliomas: new perspectives for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Gene therapy of experimental brain tumors using neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Induction of antitumor immunity using intercellular adhesion molecule 1 (ICAM-1) transfection in mouse glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Diagnosis and management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunological update on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Junctions between intimately apposed cell membranes in the vertebrate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

The cell biology of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Astrocytes induce blood–brain barrier properties in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Leukocyte traffic in the central nervous system: the participants and their roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Relationship of lymphocyte invasion and survival of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Inducing autoimmune disease to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Sequence and expression pattern of the human MAGE2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Expression of the tumor-rejection antigen SART1 in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Human glioma immunobiology in vitro: implications for immunogene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Inducible expression of H-2 and Ia antigens on brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Differential regulation and function of Fas expression on glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Interleukin-6 expression and regulation in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Cytokine-mediated inflammation and signaling in the intact central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells: role of the brain microenvironment in CNS immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Microglia induce CD4 T lymphocyte final effector function and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Production of soluble autocrine inhibitory factors by human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Selective expression of interleukin-10 gene within glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Fas and FasL in the homeostatic regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Inhibition of the alloantibody response by CD95 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Transplantation of CD95 ligand-expressing grafts: influence of transplantation site and difficulty in protecting allo- and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Fas ligand and the fate of antitumour cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Functions of nonclassical MHC and non-MHC-encoded class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

21 January 2018

HLA-G remains a mystery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

CD27/CD70 interactions regulate T dependent B cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Dendritic cell therapy of primary brain tumors

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

The role of T-cell-mediated mechanisms in virus infections of the nervous system

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Expression of cancer testis genes in human brain tumors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Glioma immunology and immunotherapy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

CTL effector function within the central nervous system requires CD4+ T cells

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Neuropathology, cell biology, and newer diagnostic methods.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Immunologically privileged sites

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782770

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

26 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01507.X

Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma

21 January 2018

1 reference

12 December 2020

TWEAK stimulation of astrocytes and the proinflammatory consequences

1 reference

12 December 2020

The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells

1 reference

12 December 2020

Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL

1 reference

12 December 2020

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

12 December 2020

Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

Antitumor effect of locally produced CD95 ligand

1 reference

12 December 2020

FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection

1 reference

12 December 2020

The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas

1 reference

12 December 2020

Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons

1 reference

12 December 2020

Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared

1 reference

12 December 2020

Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii

1 reference

12 December 2020

Tumor expression of Fas ligand (CD95L) and the consequences

1 reference

12 December 2020

Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective against Murine Intracerebral Melanoma

1 reference

12 December 2020

Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation

1 reference

12 December 2020

10.1046/J.1365-2567.2002.01507.X

Identifiers

DOI

1 reference

4 August 2017

0 references

1 reference